Both journals are anchored in large scientific societies and serve basically the same medical , physical and biological community and at the same scientific level ; the two journals are in the most recent Impact Factor list ranked almost back to back , indicating an equal importance and contribution to science .
Radiotherapy and Oncology is more than a scientific journal , it also serves other purpose s such as facilitate education through ( educational ) review s and improving the st and ard of care by bringing forward guidelines for conduct of radiotherapy .
Finally , the journal also tries to maintain a communication platform between the science produced by the membership of ESTRO and therefore it brings papers frommembers in the different European countries , sometimes at the expense of ultimate scientific quality , but with the underst and ing that it is important that the entire ESTRO membership gets access and opportunity to publish in a high ranked journal .
ESTRO , the European Society for Therapeutic Radiation Oncology , or with its new name European Society for Radiation Oncology , is a scientific society .
It means that the prime aim of ESTRO is to bring to bring people together on an individual basis who have a common interest in improving the scientific conduct of radiotherapy and cancer treatment in Europe by ensuring that proper radiotherapy is available in the multidisciplinary treatment of cancer and applied with the right indication and with the most optimal technique .
One of the main aims of this endeavour was to create a platform for scientific exchange through meetings and through the establishment of a scientific journal [ 1 ] .
Thus Radiotherapy and Oncology was launched shortly after the foundation of ESTRO and has become the society ’s prime vehicle for scientific communication by serving ESTRO members through almost the entire 30 years of the society ’s existence .
The aim was to create a peer review ed high quality international journal and that aim has indeed been fulfilled . ‘ ‘
Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
The second part of the GYN GEC ESTRO working group recommendations is focused on 3D dose-volume parameters for brachytherapy of cervical carcinoma . Methods and parameters have been developed and vali date d from dosimetric , imaging and clinical experience from different institutions ( University of Vienna , IGR Paris , University of Leuven ) . Cumulative dose volume histograms ( DVH ) are recommended for evaluation of the complex dose heterogeneity . DVH parameters for GTV , HR CTV and IR CTV are the minimum dose delivered to 90 and 100 % of the respective volume : D90 , D100 . The volume , which is enclosed by 150 or 200 % of the prescribed dose ( V150 , V200 ) , is recommended for overall assessment of high dose volumes . V100 is recommended for quality assessment only within a given treatment schedule . For Organs at Risk ( OAR ) the minimum dose in the most irradiated tissue volume is recommended for reporting : 0.1 , 1 , and 2 cm3 ; optional 5 and 10 cm3 . Underlying assumptions are : full dose of external beam therapy in the volume of interest , identical location during fractionated brachytherapy , contiguous volumes and contouring of organ walls for > 2 cm3 . Dose values are reported as absorbed dose and also taking into account different dose rates . The linear-quadratic radiobiological model-equivalent dose (EQD2)-is applied for brachytherapy and is also used for calculating dose from external beam therapy . This formalism allows systematic assessment within one patient , one centre and comparison between different centres with analysis of dose volume relations for GTV , CTV , and OAR . Recommendations for the transition period from traditional to 3D image-based cervix cancer brachytherapy are formulated . Supplementary data ( available in the electronic version of this paper ) deals with aspects of 3D imaging , radiation physics , radiation biology , dose at reference points and dimensions and volumes for the GTV and CTV ( adding to [ Haie-Meder C , Pötter R , Van Limbergen E et al. Recommendations from Gynaecological ( GYN ) GEC ESTRO Working Group ( I ) : concepts and terms in 3D image-based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV . Radiother Oncol 2005;74:235 - 245 ] ) . It is expected that the therapeutic ratio including target coverage and sparing of organs at risk can be significantly improved , if radiation dose is prescribed to a 3D image-based CTV taking into account dose volume constraints for OAR . However , prospect i ve use of these recommendations in the clinical context is warranted , to further explore and develop the potential of 3D image-based cervix cancer brachytherapy
Both journals are anchored in large scientific societies and serve basically the same medical , physical and biological community and at the same scientific level ; the two journals are in the most recent Impact Factor list ranked almost back to back , indicating an equal importance and contribution to science .
Radiotherapy and Oncology is more than a scientific journal , it also serves other purpose s such as facilitate education through ( educational ) review s and improving the st and ard of care by bringing forward guidelines for conduct of radiotherapy .
Finally , the journal also tries to maintain a communication platform between the science produced by the membership of ESTRO and therefore it brings papers frommembers in the different European countries , sometimes at the expense of ultimate scientific quality , but with the underst and ing that it is important that the entire ESTRO membership gets access and opportunity to publish in a high ranked journal .
ESTRO , the European Society for Therapeutic Radiation Oncology , or with its new name European Society for Radiation Oncology , is a scientific society .
It means that the prime aim of ESTRO is to bring to bring people together on an individual basis who have a common interest in improving the scientific conduct of radiotherapy and cancer treatment in Europe by ensuring that proper radiotherapy is available in the multidisciplinary treatment of cancer and applied with the right indication and with the most optimal technique .
One of the main aims of this endeavour was to create a platform for scientific exchange through meetings and through the establishment of a scientific journal [ 1 ] .
Thus Radiotherapy and Oncology was launched shortly after the foundation of ESTRO and has become the society ’s prime vehicle for scientific communication by serving ESTRO members through almost the entire 30 years of the society ’s existence .
The aim was to create a peer review ed high quality international journal and that aim has indeed been fulfilled . ‘ ‘